Please assess the completion status of the following clinical trial:

Trial Title: Spinal Morphine in Robotic Assisted Radical Prostatectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled for Robot-Assisted Radical Prostatectomy~Exclusion Criteria:~* Contra-indications to spinal anesthesia (severe aortic stenosis, coagulation disorders)~* Contra-indications to study medication (local anesthetics, morphine, paracetamol, metamizol)~* Conversion to an open procedure~* Post-operative ICU-admission

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: SHAM_COMPARATOR): subcutaneous lidocaïne and intravenous loading dose of morphine
- Intervention (Type: EXPERIMENTAL): Spinal injection of 4 or 5 ml of bupivacaine/morphine 2,5 mg/ml/60mcg/ml. The reduction to 4 ml is for patients over 75 years of age

Based on this trial design, predict the completion outcome and termination type (if applicable).